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SUMMARY
Strongyloides ratti larval extract was used for the standardization of ELISA to detect genus-specific IgE in human strongyloidiasis.
Forty serum samples from monoinfected patients shedding S. stercoralis larvae (Group I), 40 from patients with other intestinal
parasites (Group II), and 40 from copronegative healthy subjects (Group III) were analyzed. Genus-specific IgE levels (ELISA Index:
EI) were significantly higher in the group I (EI = 1.43) than groups II (EI = 0.70) and III (EI = 0.71), showing positivity rates of 55%,
2.5% and 0%, respectively. Similarly, sera from copropositive patients had significantly higher levels of total IgE (866 IU/mL) as
compared to those from group II (302 IU/mL) and III (143 IU/mL). A significant positive correlation was found between levels of
Strongyloides specific-IgE and total IgE in sera from patients with strongyloidiasis. In conclusion, S. ratti heterologous extract
showed to be a useful tool for detecting genus-specific IgE by ELISA, contributing for a better characterization of the immune
response profile in human strongyloidiasis.
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INTRODUCTION
Strongyloides stercoralis causes chronic or subclinical intestinal
infections in immunocompetent human hosts due to the occurrence of
autoinfective larvae, which contribute to the maintenance of the
population of adult worms in the intestine. S. stercoralis has unique
feature of moulting from parasitic form to infective stage within the
body rather than coming out and forming for indefinite period in an
immunocompetent host. In addition, fatal hyperinfection or disseminated
infection may occur in immunocompromised subjects like patients with
cancer, organ transplant recipients, acquired immunodeficiency syndrome
(AIDS), and patients upon corticoids and other immunosuppressive
therapy, in whom it can involve any organ of the body1,10,29.
Strongyloidiasis is one of the most difficult parasitic infections to
diagnose. Parasitological methods have poor sensitivity due to low
parasite load or fluctuations of larval excretion in the majority of the
infected individuals and they are time-consuming procedures9,31. In
contrast, serological tests are more sensitive but the detection of specific
IgG by enzyme-linked immunosorbent assay (ELISA) has shown cross-
reactivity with other helminth parasites6,12.
Although the IgE isotype is mainly associated with allergic responses
and classified as type I hipersensitivity16, its relationship with helminth,
protozoan and viral infections has been reported15,21,30. In human
strongyloidiasis specific serum IgE levels using S. stercoralis antigen
have been detected by radioimmunoallergosorbent test (RAST)13,20,
ELISA2,4,23 and immunoblotting assay4.
The major limitation found in the development of immunological
tests for the diagnosis of strongyloidiasis is the low S. stercoralis larvae
burden and consequently its low antigen recovery levels8. As
Strongyloides ratti is readily maintained in laboratory rats it may represent
a practical source of antigen. Immunological tests using S. stercoralis
and S. ratti third-stage filariform larvae have shown comparable
results7,14,27.
Since in previous reports S. ratti antigens have not been employed
for the detection of specific IgE, in this study we applied an IgE-ELISA
using such heterologous antigen in human strongyloidiasis.
MATERIAL AND METHODS
Patients and serum samples: Serum samples were obtained from
patients attended at the Hospital de Clínicas da Universidade Federal de
Uberlândia, Minas Gerais, Brazil and divided into three groups based on
the parasitological results according to the FERRIOLI11 and LUTZ19
methods. Serum samples of 120 individuals were analyzed, from which
40 were from monoinfected patients shedding S. stercoralis larvae in their
feces (Group I; copropositive and seropositive for IgG anti-S. ratti; 23
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male, 17 female; age = 36.4 ± 15.5 years). Group II consisted of 40 serum
samples from monoinfected patients (14 male, 26 female; age = 18.7 ±
13.6 years) with other intestinal parasites, such as hookworm (9 cases),
Enterobius vermicularis (8 cases), Hymenolepis nana (6 cases), Trichuris
trichiura (6 cases), Ascaris lumbricoides (5 cases), and Giardia lamblia
(6 cases). Group III included 40 serum samples from healthy subjects
who had repeatedly negative stool exams (copronegative; 23 male, 17
female; age = 27.0 ± 13.1 years). All subjects of groups II and III were
seronegative for IgG anti-S. ratti. The protocol was approved by the
Research Ethics Committee of the Universidade Federal de Uberlândia
(CEP 28/2000), according to the federal Brazilian regulations22.
Parasites: S. ratti larvae were obtained from the feces of
experimentally infected rats (Rattus rattus). The larvae were mixed with
an equal part of finely ground charcoal, moistened with water, spread in
a uniform layer on Petri dishes and incubated at 25 °C for 5 days. The
filariform larvae were then harvested according to the FERRIOLI11
technique, concentrated by centrifugation at 1,000 x g for 5 min and
stored at –20 °C for using in the heterologous antigen preparation.
Heterologous antigen extract: S. ratti filariform larvae (90,000)
were suspended in 3 mL of 0.01 M phosphate-buffered saline (PBS),
pH 7.2, and then submitted to four sonication cycles for 5 min on ice
bath at 40 kHz (Thorton, Inpec Eletrônica São Paulo, SP, Brazil). After
incubation overnight at 4 °C under continuous agitation, the antigen
extract was centrifuged at 3,000 x g at 4 ºC for 30 min. Next, the protein
concentration of the supernatant was determined according to LOWRY
et al.18 and stored at –20 oC for using as saline extract in ELISA.
Genus-specific serum IgE by ELISA: Specific IgE antibodies to
Strongyloides sp. were measured in serum samples from groups I, II and
III by indirect ELISA using a heterologous antigen extract, according to
the described protocol by SILVA et al.28 with modifications. Briefly,
microtiter plates were coated with 10 µg/mL of S. ratti saline extract in
0.06 M carbonate buffer, pH 9.6, overnight at 4 °C. Plates were washed
in PBS containing 0.05% Tween 20 (PBS-T) and blocked with PBS-T
plus 1% bovine serum albumin (PBS-T-BSA) for one hour at room
temperature (RT). Subsequent steps were carried out using PBS-T-BSA
as diluent, and washings in PBS-T were done between the steps of the
reaction. The plates were incubated with serum samples diluted at 1:2 in
duplicate for 2 h at RT. Subsequently, biotinylated goat anti-human IgE
(Kirkegaard & Perry Laboratories Inc, Baltimore, MD, USA) was added
(1:1000) and incubated for 1h at RT, and further streptavidin-peroxidase
conjugate (Sigma Chemical Co., St. Louis, MD, USA) diluted at 1:1000
was incubated for 30 min at RT. The assay was developed by adding the
enzyme substrate (0.01M ABTS and 0.03% H202), and the absorbance
(Abs) was read at 405 nm in a plate reader (Titertek Multiskan Plus,
Flow Laboratories, USA). Positive and negative control sera were
included in each assay. Positive serum was obtained from a patient who
was shedding S. stercoralis larvae in the feces, and negative sera were
obtained from four healthy subjects. The results were arbitrarily expressed
as ELISA Index (EI) and calculated as follows: EI = Abs of serum sample
/ cut off, where cut off was determined as the mean absorbance of the
negative control sera plus 5 standard deviations. Values of EI > 1.0 were
considered as positive.
Total serum IgE: A monoclonal antibody-based ELISA, modified
from a previously described radioimmunoassay (RIA) by POLLART et
al.24, was used for measuring total IgE antibodies. Briefly, microtiter plates
were coated with mouse monoclonal anti-human IgE (Sigma Chemical
Co.) at 1:5,000 in 0.06 M carbonate buffer pH 9.6 overnight at 4 °C.
Plates were washed and blocked as previously described. Serum samples
diluted at 1:5, 1:25 and 1:125 were incubated for one hour at RT.
Biotinylated goat anti-human IgE (Kirkegaard & Perry Laboratories Inc.)
diluted at 1:4,000 was added and incubated for one hour at RT. Subsequent
steps (streptavidin-peroxidase and enzyme substrate) were carried out as
described for specific IgE-ELISA. Total IgE results were expressed as
international units per milliliter of serum and calculated based on a control
curve obtained by serial two-fold dilutions of a serum (subject ARN) that
was designated as containing 3,000 IU/mL of total IgE. As reported by
ROSE et al. (1996)26, 1 IU/mL represents about 2.4 ng/mL of IgE.
Statistical analysis: Determinations of geometric means (gm) with
95% confidence intervals (CI) were calculated and the differences
between the means were analyzed by the unpaired Student t test. The
group comparisons were performed using the differences between two
proportions by Z statistic. Levels of total and Strongyloides-specific serum
IgE were analyzed by Spearman correlation test. Values of p < 0.05
were regarded as statistically significant.
RESULTS
As demonstrated in Figure 1, levels of Strongyloides-specific IgE
(expressed in EI) were significantly higher (p < 0.0001) in copropositive
patients (group I) (gm:1.43; 95% CI: 1.17 - 1.75) than those obtained in
patients with other parasites (group II) (gm: 0.70; 95% CI: 0.67 - 0.73)
and copronegative subjects (group III) (gm: 0.71; 95% CI: 0.69 - 0.74).
Similarly, samples obtained from copropositive patients had significantly
higher levels of total IgE (gm: 866 IU/mL; 95% CI: 438 - 1,706) than
those from the group II (gm: 302 IU/mL; 95% CI: 163 - 558) and group
III (gm: 143 IU/mL; 95% CI: 48 - 424). However, no significant difference
was found in the levels of both specific and total IgE between the two last
groups (p > 0.05). Thus, the positivity rate for IgE anti-Strongyloides was
55% in the copropositive group compared with 2.5% in the group with
other parasites and 0% in the copronegative group (p < 0.001).
Figure 2 shows a significant positive correlation (Spearman r =
0.6326; p < 0.0001) between levels of Strongyloides-specific IgE and
total IgE in sera from patients with strongyloidiasis (Group I).
Furthermore, 21/22 (95.4%) patients with IgE anti-Strongyloides had a
total IgE value greater than 100 IU/mL and 20/22 (90.9%) showed values
greater than 1000 IU/mL of total IgE.
DISCUSSION
Human strongyloidiasis is usually an asymptomatic or chronic
infection in immunocompetent hosts, but it can be a severe parasitosis
with potentially fatal auto-infection in immunocompromised subjects.
The majority of the cases are underdiagnosed due to the lack of defined
symptoms, thus contributing for the infection dissemination, particularly
in tropical and subtropical countries9. The difficult mass production of
S. stercoralis larvae, with the involved risk of infectivity for laboratory
technicians, can be avoided because of the feasibility of safe and easy
mass production of S. ratti larvae, an adequate substitute antigen, as
proven in our previous studies using indirect immunofluorescence
reaction7.
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For several years the detection of specific IgE to S. stercoralis had
been performed by RAST using hazardous and radioactive material as
well as expensive specific equipments13,20. The application of ELISA2,23
for the detection of human IgE anti-Strongyloides stercoralis, due to its
high sensitivity and practicability, has helped the diagnosis by reducing
costs and working under biosafety conditions.
The role of IgE antibodies has been implicated in acquired resistance
to autoinfection in strongyloidiasis, resulting in a decrease in infection
intensity and a consequent reduction in larval output. Therefore, IgE-
mediated responses may be essential in regulating autoinfection4.
The results of this study showed that the genus-specific serum IgE
levels and positivity rate in the strongyloidiasis patients were significantly
higher than those found in patients with other parasitic infections and
healthy subjects. ATKINS et al.2 have demonstrated that levels of specific
IgE to S. stercoralis were more elevated in serum from patients in recent
than long standing chronic infection, suggesting that IgE levels are
downregulated with increasing duration of infection.
According to NEVA et al.23, specific serum IgE levels are also much
higher in patients infected with S. stercoralis as compared to co-infected
patients with S. stercoralis and human T lymphotropic virus type I
(HTLV-I). Thus, the HTLV-I infection associated to hyperinfection and
disseminated strongyloidiasis is also related to supressed IgE antibody
response3,25.
In this study, the levels of total serum IgE were significantly higher
in the group of patients with strongyloidiasis than in the other groups, as
observed by others5,13,17. When comparing the levels of Strongyloides-
specific IgE and total IgE in sera from patients with strongyloidiasis a
good and significant positive correlation was found, indicating that the
high levels of total IgE seen in these patients were associated with the
disease. In addition, the great majority of the patients with
strongyloidiasis had a level higher than 1,000 IU/mL of total IgE.
Taken together, it can be concluded that the employment of
heterologous saline extract (S. ratti) showed to be a useful tool for the
detection of genus-specific IgE antibodies by ELISA, contributing for a
better characterization of the immune response profile in human
strongyloidiasis.
RESUMO
Extrato antigênico heterólogo em ELISA para a detecção de IgE
humana anti-Strongyloides stercoralis
Extrato contendo larvas de Strongyloides ratti foi usado na
padronização de um ELISA para detecção de IgE gênero-específica na
estrongiloidíase humana. Foram analisadas 40 amostras de soro de
pacientes monoinfectados que estavam eliminando larvas de S. stercoralis
nas fezes (Grupo I), 40 de pacientes com outros parasitos intestinais
(Grupo II), e 40 indivíduos copronegativos (Grupo III). Níveis de IgE
gênero-específica (índice ELISA: EI) foram significativamente maiores
no Grupo I (EI = 1,43) do que no II (EI = 0,70) e III (EI = 0,71), mostrando
Fig. 1 - Levels of Strongyloides-specific IgE (A) expressed in ELISA Index (EI) and total IgE
(B) expressed in IU/mL, determined by ELISA in serum samples from patients with
strongyloidiasis (Group I; n = 40), other intestinal parasites (Group II; n = 40) and healthy
subjects who had repeatedly negative stool examination (Group III; n = 40). The dashed line
in Fig. 1A represents the ELISA cut off (EI > 1.0). The horizontal bars in Fig. 1B indicate the
geometric mean (gm) of the total IgE levels (IU/mL) in each group. *p < 0.05; **p < 0.01;
***p < 0.0001.
Fig. 2 - Correlation between levels of Strongyloides-specific IgE (EI) and total IgE (IU/mL)
in serum samples from patients with strongyloidiasis (Group I; n = 40), using Spearman
correlation test. The dashed lines represent the cut off level of 1.0 EI for genus-specific IgE
and the arbitrarily considered values of 100 and 1000 IU/mL for total IgE levels.
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positividade de 55%, 2,5% e 0%, respectivamente. Similarmente, soros
dos pacientes copropositivos (Grupo I) apresentaram níveis significa-
tivamente maiores de IgE total (866 IU/mL) quando comparados com
os soros dos Grupo II (302 IU/mL) e III (143 IU/mL). Uma significativa
correlação positiva foi encontrada entre os níveis de IgE específica a
Strongyloides sp. e IgE total nos soros de pacientes com estrongiloidíase.
Em conclusão, extrato heterólogo de S. ratti mostrou ser uma ferramenta
útil para detecção de IgE gênero-específica por ELISA, desta forma
contribuindo para melhor caracterização do perfil da resposta imune na
estrongiloidíase humana.
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